Rad AI Secures $8M More, Hits $68M in Series C
Slice of Healthcare Team
May 22, 2025
Key highlights
- Rad AI raises an additional $8M, bringing Series C total to $68 million.
- Investment led by Advocate Health, Memorial Hermann, Corewell Health, and Atlantic Health System.
- Rad AI is the first generative AI company with wide adoption in radiology.
- Solutions support providers handling nearly half of all U.S. imaging volume.
- Tools like Rad AI Impressions, Reporting, and Continuity are transforming workflow and patient follow-up.
Notable Quotes
“ The impact of AI in healthcare is no longer theoretical — it's happening right now at scale. ”
Doktor Gurson, Co-founder and CEO at Rad AI
“ We expect to realize improved reporting efficiency, accuracy and quality, all while reducing burnout for our radiologists. ”
Andy Crowder, Chief Digital and AI Officer at Advocate Health
“ Rad AI checks all those boxes. ”
Feby Abraham, PhD, EVP and Chief Strategy Officer at Memorial Hermann
“ We are pleased to invest in a company that is at the forefront of developing technology to make the jobs of physicians more convenient and efficient. ”
Christian Rische, VP & MD at Corewell Health Ventures
“ Our investment in AI applications like Rad AI are focused on transforming care. ”
Doug Hayes, Executive Director at Atlantic Venture Studio
Why This Matters
This strategic expansion underscores the healthcare industry's shift from piloting AI to integrating it as a core clinical tool. By securing investment from four powerhouse health systems, Rad AI reinforces its credibility and capacity to scale its impact. Its comprehensive suite — automating reports, easing radiologist workloads, and ensuring patient follow-up — directly addresses the sector’s most pressing operational and quality challenges. As generative AI moves from buzzword to backbone, Rad AI stands out as a proven, scalable force shaping the future of clinical care.
